Get 20% lifetime commission for referring investors to digrin.com
here.
IGC Pharma, Inc. ( IGC) - Stock Earnings
IGC Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 13, 2026, midnight | — / — | — | — / — | — |
IGC Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -726000 USD | 350000 USD |
| 2026Q1 | -2.4 million USD | 317000 USD |
| 2026Q2 | -2.9 million USD | 265000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
IGC Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -13.0 million USD | 1.3 million USD |
| 2025 | -7.1 million USD | 1.3 million USD |
| 2026 | -6.5 million USD | 1.2 million USD |
| 2026 Est. | — | — |
IGC
Price: $0.25
52 week price:
Earnings Per Share: -0.06 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 122069
Market Capitalization: 28.0 million